Lianyungang Shenghe Biotechnology Co., Ltd. is primarily engaged in the research, development, and production of intermediates for antitumor drugs. The company has complete environmental, safety, and fire protection certifications, well-equipped public utilities, and relatively comprehensive analytical testing equipment including liquid chromatographs and gas chromatographs. It has also established a robust quality management system. The company has built a municipal-level technology center, is recognized as a municipal high-tech enterprise, and has jointly established a green synthesis laboratory with the Jiangsu Marine Resources Research Institute.

"Technology is the primary productive force" and "Technology shapes the future." Adhering to a strategy centered on technology and talent, the company currently employs two doctors, with master's and bachelor's degree holders accounting for over 60% of its workforce. Additionally, several domestic and international experts in drug synthesis are retained to provide ongoing guidance for the company's R&D efforts. The company has developed its own distinctive features in the research and development of antitumor drug intermediates and possesses multiple advanced technologies. With extensive experience in R&D, production, and operations, the company has grown into a highly competitive producer and supplier of antitumor drug intermediates in China.

We sincerely welcome friends from all sectors to discuss and collaborate on exploring domestic and international markets, working together to create a brighter future.